D. E. Shaw & Co., Inc. Insmed Inc Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Insmed Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 288,551 shares of INSM stock, worth $21 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
288,551
Previous 174,022
65.81%
Holding current value
$21 Million
Previous $4.72 Million
309.49%
% of portfolio
0.02%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding INSM
# of Institutions
447Shares Held
170MCall Options Held
5.79MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA16MShares$1.17 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$887 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA5.87MShares$428 Million0.08% of portfolio
-
State Street Corp Boston, MA4.66MShares$340 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.88B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...